Previous research demonstrated that COX-2 achieved cancer-promoting effects mainly by its downstream prostaglandins, which contributed to cancer initiation, progression and resistance to treatment (Hashemi Goradel et al., 2019; Hou et al., 2021). Here, PTGS2 is linked to cancer.